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We examined the relation with birth weight and umbilical cord blood concentrations of haematopoietic stem and progenitor
populations in 288 singleton infants. Across the whole range of birth weight, there was a positive relation between birth weight and
CD34
þCD38
  cells, with each 500g increase in birth weight being associated with a 15.5% higher (95% confidence interval: 1.6–
31.3%) cell concentration. CD34
þ and CD34
þc-kit
þ cells had J-shaped relations and CFU-GM cells had a U-shaped relation with
birth weight. Among newborns with X3000g birth weights, concentrations of these cells increased with birth weight, while those
below 3000g had higher stem cell concentrations than the reference category of 3000–3499g. Adjustment for cord blood plasma
insulin-like growth factor-1 levels weakened the stem and progenitor cell–birth weight associations. The positive associations
between birth weight and stem cell measurements for term newborns with a normal-to-high birth weight support the stem cell
burden hypothesis of cancer risk.
British Journal of Cancer (2008) 98, 660–663. doi:10.1038/sj.bjc.6604183 www.bjcancer.com
Published online 5 February 2008
& 2008 Cancer Research UK
Keywords: birth weight; cancer risk; prenatal exposure; stem cell
                                                
The in utero environment and perinatal factors may influence
cancer risk of the offspring later in life (Trichopoulos, 1990). One
parameter that reflects in utero/perinatal influences, that is birth
weight, has been positively correlated with subsequent risk of
childhood cancer (Schu ¨z and Forman, 2007) and, in adults, breast
(Michels and Xue, 2006), prostate (Eriksson et al, 2007) and
colorectal cancers (Nilsen et al, 2005) and, indeed, overall cancer
risk (Ahlgren et al, 2007). Mechanistically, a ‘stem cell burden’
theory (Adami et al, 1995) has been proposed to account for the
positive relationship between birth weight and the risk of certain
cancers, especially that of the breast. By this hypothesis, the levels
of in utero/perinatal mitogens and other factors determine the size
of the stem cell pools in the developing fetus; elevated tissue stem
cell numbers drive the formation of larger organs and hence might
be associated with larger birth weights. The greater the stem cell
pool size, however, the greater the chance that one of the stem cells
will be mutated by a carcinogen, or undergo a DNA replicative
error, initiating oncogenic transformation. Hence, individuals with
high birth weights might be at greater lifetime cancer risk
(Trichopoulos et al, 2005).
The stem cell burden theory predicts (1) that the in utero levels
of particular mitogens should correlate positively with stem cell
population levels and (2) that the stem cell levels should correlate
positively with birth weight. In a previous study, we demonstrated
that the umbilical cord blood concentrations of various haemato-
poietic stem and progenitor populations correlated with cord
blood plasma levels of particular mitogens, especially insulin-like
growth factor-1 (IGF-1) (Savarese et al, 2007). Here, we determine
whether or not these measurable haematopoietic stem cell/
progenitor values, serving as surrogates of overall stem cell
potential, are positively associated with birth weight.
MATERIALS AND METHODS
The umbilical cord blood study protocol was approved by the
institutional review boards of the American Red Cross, the
University of Massachusetts Medical School, the University of
Massachusetts/Memorial Health Care System, St. Vincent’s
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Consenting study subjects were recruited from one of two sources:
(1) participants in the Worcester, MA-based American Red Cross
cord blood program (ACBP), in which a haematopoietic stem cells
from umbilical cord blood were collected for possible transplanta-
tion, from August 2002 to June 2003, and (2) pregnant women
delivering at T-NEMC from October 2004 to April 2006. All the
cord blood samples were from full-term (gestational age X37
weeks) singleton infants. The processing of samples, which
includes the determination of cord blood volumes, the determina-
tion of initial levels of total nucleated cells (TNC) and mono-
nuclear cells (MNC) before centrifugations or manipulation, the
quantitation of haematopoietic stem/progenitor cell populations
and the determination of cord blood plasma hormone levels, have
been described (Savarese et al, 2007). The haematopoietic stem
and progenitor populations that were quantitated (1) CD34
þ cells,
a heterogeneous population of early multipotent stem and
progenitor cells, committed progenitors and differentiating cells
(Xiao and Dooley, 2000); (2) CD34
þCD38
  cells, which represent
more primitive stem cells depleted of lineage-committed pre-
cursors (Xiao and Dooley, 2000); (3) CD34
þc-kit
þ cells, which
also represent a more primitive stem cell population that has
relatively high cloning efficiencies in semisolid culture (Sharkey
et al, 1994; Mayani and Lansdorp, 1998); and (4) granulocyte–
macrophage colony forming units (CFU-GM), a functional
measure of the number of proliferative granulocyte/macrophage-
committed haematopoietic precursor cells (Abboud et al, 1992;
Hoffbrand et al, 2001).
Birth weight was first studied as a categorical variable (o3000,
3000–3499, 3500–3999 and X4000g). Geometric means for the
stem cell measurements were estimated within the indicated
categories of birth weight. Multivariate linear regression was used
to examine the association between natural log-transformed
measures of stem cell potential (dependent variable) and birth
weight (independent variable, using 3000–3499g as the reference),
adjusting for maternal and neonatal characteristics (mother’s age,
race of parents, number of live births, gestation duration, baby’s
gender, delivery time and study site). To assess whether there was
an underlying linear trend, birth weight was next analyzed as a
continuous variable across the whole range of birth weight values
with the effect estimates expressed for each 500g increase in birth
weight. The fitted coefficients from the regression analyses were
exponentiated to obtain the estimated proportional change in birth
weight associated with each independent variable. Statistical
significance was set at 0.05 (two-sided). Levels of IGF-1, which
had the strongest association with levels of stem cells among the
hormones and growth factors examined in a previous analysis
(Savarese et al, 2007), were further adjusted to explore its influence on
the association between birth weight and stem cell measurements.
RESULTS
The characteristics of the study subjects are shown in Table 1.
Subjects from the ACBP and T-NEMC patient groups had similar
age and gestation duration. Parental ethnicity was more varied in
the T-NEMC samples, while the ACBP subjects had higher parities,
more male newborns and lower birth weights.
The associations were analysed in multivariate analysis adjust-
ing for maternal age, parental race, parity, gestation duration,
gender, delivery time and study site (Table 2, upper panel). There
was a J-shaped association between birth weight categories and
concentrations of TNC (lymphocytes, monocytes and granulo-
cytes), as well as a J-shaped relation with MNC (lymphocytes and
monocytes), both including more differentiated cells. Among
the stem cell populations, there was a positive association with
CD34
þCD38
  cells across the whole range of birth weight
categories, with each 500g increase being associated with 15.5%
higher levels of this cell population (95% confidence interval: 1.6,
31.3%). A J-shaped relation was observed for the CD34
þ and
CD34
þc-kit
þ cells: for birth weights of 3000g or greater, stem cell
concentrations increased with birth weight, while the lowest
category of o3000g had higher levels than the category of 3000–
3499g. For CFU-GM, an approximate U-shaped relation was
observed, with the lowest birth weight category having the highest
levels of this cell population (Table 2, upper panel).
Adjusting for cord blood plasma levels of IGF-1 in the
multivariate analysis weakens the association (Table 2, lower
panel). The association with CD34
þCD38
  remained positive but
was no longer statistically significant: each 500g increase in birth
weight was associated with a 7.9% increase in this cell sub-
population (95% confidence interval:  6.2, 24.0%). The lowest
weight category continued to have the highest CFU-GM cells after
adjusting for IGF-1 levels.
We conducted further analyses adjusting for other hormones
and in samples from different ethnic groups. Adjusting for estriol
or insulin-like growth factor binding protein-3, which had
statistically significant but weaker associations with cord blood
levels of stem cells (Savarese et al, 2007), in place of IGF-1, had
much less effect on the association with birth weight (data not
shown). A linear relation between stem cell measurements and
birth weight was observed for newborns whose parents were
Caucasian, but did not have a consistent shape among samples in
the mixed non-Caucasian group (Table 3).
DISCUSSION
The stem cell burden hypothesis has been invoked as an
explanation for the positive link between birth weight and risk
for both childhood and adult cancers (Adami et al, 1995). This
hypothesis proposes that in utero environments that promote
Table 1 Characteristics of the study subjects by study site
ACBP (n¼39) T-NEMC (n¼249)
Characteristics Mean±s.d. or N (%) Mean±s.d. or N (%)
Mother’s age (years) 29.7±5.1 30.1±5.6
Parity
1 14 (35.9) 104 (45.0)
2 12 (30.8) 64 (27.7)
3 7 (18.0) 39 (16.9)
4 or more 6 (15.4) 24 (10.4)
Race/ethnicity of mother and biological father
Both Caucasian 36 (92.3) 111 (52.4)
Both African-American 1 (2.6) 19 (9.0)
Both Asian 0 (0.0) 39 (18.4)
Both Hispanic 0 (0.0) 14 (6.6)
Mixed 2 (5.1) 29 (13.7)
Gestation duration (weeks) 39.6±1.4 39.6±1.2
Newborn gender
Male 21 (55.3) 113 (50.0)
Female 17 (44.7) 113 (50.0)
Birth weight (g) 3313.1±450.6 3416.4±428.2
o3000 11 (28.2) 40 (16.1)
3000–3499 15 (38.5) 110 (44.2)
3500–3999 11 (28.2) 77 (30.9)
X4000 2 (5.1) 22 (8.8)
Abbreviations: ACBP¼American Red Cross Cord Blood Program; T-NEMC¼
Tufts-New England Medical Center. Data on some variables were unavailable for
subjects with missing values.
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weights; the larger the stem cell pool, the greater the risk that one
of these stem cells will undergo malignant transformation. In
support of the first tenet of this hypothesis, we have demonstrated
that the concentrations of stem and progenitor cell populations in
umbilical cord blood, serving as surrogates for overall stem cell
potential, correlate with cord blood plasma levels of certain
mitogens, notably IGF-1 (Savarese et al, 2007). The hypothesis also
predicts that newborns with high birth weights should have
elevated stem cell populations. Our findings indicate that there is a
positive association between birth weight and haematopoietic stem
cell measurements in the cord blood samples among newborns
with normal-to-high (X3000g) birth weights. This association is
strongest with CD34
þCD38
  cells, a relatively primitive haema-
topoietic stem cell population. These data are in line with previous
studies, which showed a positive relationship between cord blood
CD34
þ or CFU-GM levels and birth weight (Shlebak et al, 1998;
Ballen et al, 2001; Aroviita et al, 2004).
However, in our study, newborns in the lowest birth weight
category (o3000g) can have higher levels of stem/progenitor cell
measurements than those with 3000–3499g birth weight resulting
in a J- or U-shaped relation between stem cell levels and birth
weight. This finding is intriguing, as J- or U-shaped relationships
have often been observed in childhood cancers (Schu ¨z and
Forman, 2007) and neurological (Schu ¨z et al, 2001; Von Behren
and Reynolds, 2003), prostate (Eriksson et al, 2007), colorectal
(Nilsen et al, 2005) and early-onset breast cancers (Sanderson et al,
1996; Innes et al, 2000; Mellemkjaer et al, 2003).
The possible elevated levels of stem cells at low birth weight
warrant further investigations. Using birth weight to define small-
for-gestation for full-term healthy infants, a majority (486%) of
such infants undergo accelerated growth during the first 6–12
months after birth and attain normal height later in life (Karlberg
and Albertsson-Wikland, 1995). Premature infants (i.e., those born
before the 33rd gestational week, generally with low birth weights)
have been shown to have elevated foetal and cord blood CD34
þ
and CD34
þCD38
  levels relative to full-term infants (most with a
normal birth weight) (Shields and Andrews, 1998; Wyrsch et al,
1999). Relevant to this phenomenon, it has been reported that
premature female newborns have an increased risk for breast
cancer later in life (Ekbom et al, 2000). It is not known whether
premature or small newborns harbour elevated stem/progenitor
Table 2 Multiple linear regression analysis for the association between measurements of haematopoietic stem cell populations and birth weight
Birth weight (g) in categories Birth weight per
500g
Analytic model
Cell
measurements
o3000 %
Difference
(95% CI)
3000–3499
Reference
(geometric
mean
a)
3500–3999 %
Difference
(95% CI)
X4000 %
Difference
(95% CI)
% Difference
(95% CI)
Adjusted for core
covariates
b
TNC 2.1 ( 8.5, 14.0) 0.0 (15.00) 7.8 ( 1.7, 18.3) 8.4 ( 8.1, 27.8) 3.0 ( 2.5, 8.9)
MNC 5.7 ( 6.4, 19.3) 0.0 (6.91) 6.5 ( 3.9, 18.0) 12.5 ( 6.2, 34.9) 2.1 ( 3.9, 8.4)
CD34
+
c
2.4 ( 19.2, 29.7) 0.0 (7.04) 12.5 ( 8.1, 37.7) 20.8 ( 15.5, 72.8) 9.5 ( 2.6, 23.2)
CD34
+CD38
 
c
 1.1 ( 23.6, 28.1) 0.0 (3.11) 19.1 ( 4.3, 48.1) 47.9 (0.4, 117.8) 15.5 (1.6, 31.3)
CD34
+c-kit
+
d
13.7 ( 14.0, 50.4) 0.0 (5.80) 18.9 ( 5.5, 49.6) 34.2 ( 10.4, 101.1) 10.0 ( 4.0, 26.1)
CFU-GM
e 37.0 (2.1, 83.8) 0.0 (4.04) 29.0 ( 0.1, 66.6) 31.4 ( 16.2, 106.1) 6.1 ( 8.4, 23.0)
Adjusted for core
covariates and IGF-1
TNC 0.6 ( 10.0, 12.5) 0.0 (15.00) 9.7 ( 0.4, 20.8) 12.3 ( 5.5, 33.4) 4.5 ( 1.5, 11.0)
MNC 4.0 ( 8.0, 17.7) 0.0 (6.91) 8.5 ( 2.5, 20.6) 16.8 ( 3.5, 41.4) 3.7 ( 2.9, 10.8)
CD34
+
c
11.0 ( 12.3, 40.6) 0.0 (7.04) 2.5 ( 16.5, 25.8)  0.3 ( 31.0, 44.0) 0.6 ( 11.4, 14.2)
CD34
+CD38
 
c
5.2 ( 19.0, 36.6) 0.0 (3.11) 10.9 ( 11.5, 38.8) 27.6 ( 14.7, 90.9) 7.9 ( 6.2, 24.0)
CD34
+c-kit
+
d
22.8 ( 6.9, 62.1) 0.0 (5.80) 7.0 ( 15.3, 35.2) 10.5 ( 26.9, 66.9) 0.7 ( 12.9, 16.4)
CFU-GM
e 45.6 (8.6, 95.1) 0.0 (4.04) 15.5 ( 11.6, 50.9) 11.5 ( 29.8, 77.1)  1.7 ( 16.2, 15.3)
aUnadjusted geometric means. TNC, initial total nucleated cells 10
6 per ml; MNC, initial mononuclear cells 10
6 per ml; the unit for the stem cell populations (CD34
+,
CD34
+CD38
 , CD34
+c-kit
+, and CFU-GM) was per 1000 MNC.
bCore covariates included mother’s age, race of parents (both Caucasian or not), parity, gestation duration,
gender of baby (male or female), delivery time (night or day) and study site (ACBP or T-NEMC).
cn¼233 with complete information on all the covariates.
dDetermined only in
the T-NEMC-derived samples.
eData from the T-NEMC-derived samples on which this assay was conducted. Statistical significance of Po0.05 are given in bold.
Table 3 Ethnic-specific, core covariate-adjusted
a multiple linear regression analysis for the association between measurements of haematopoietic stem cell
populations and birth weight
Birth weight (g) in categories Birth weight per
500g
Ethnicity
Stem cell
measurements
o3000 %
Difference
(95% CI)
3000–3499
Reference
(geometric
mean
b)
3500–3999 %
Difference
(95% CI)
X4000 %
Difference
(95% CI)
% Difference
(95% CI)
Both parents
Caucasian
CD34
+  13.9 ( 37.2, 18.0) 0.0 (7.73) 8.3 ( 15.2, 38.3) 37.5 ( 11.2, 113.1) 16.6 (0.9, 34.7)
CD34
+CD38
   18.0 ( 43.0, 17.9) 0.0 (3.41) 14.3 ( 13.7, 51.4) 80.5 (9.1, 198.7) 23.8 (4.7, 46.4)
CD34
+c-kit
+  11.5 ( 40.8, 32.3) 0.0 (6.44) 18.4 ( 11.0, 57.5) 63.4 ( 1.0, 169.5) 22.9 (3.6, 45.8)
CFU-GM 19.3 ( 25.9, 92.8) 0.0 (4.01) 36.9 ( 3.4, 94.1) 40.0 ( 25.3, 162.5) 19.7 ( 3.3, 48.2)
Either parent non-
Caucasian
CD34
+ 28.4( 12.1, 87.6) 0.0 (6.47) 19.9 ( 16.6, 72.3)  0.6 ( 46.6, 85.3) 0.5 ( 18.1, 23.5)
CD34
+CD38
  23.2 ( 16.2, 81.2) 0.0 (2.84) 28.2 ( 10.8, 84.4) 13.5 ( 39.1, 111.7) 6.3 ( 13.8, 31.0)
CD34
+c-kit
+ 42.1 ( 6.2, 115.5) 0.0 (5.39) 22.2 ( 17.2, 80.4) 9.2 ( 43.9, 112.6)  0.4 ( 20.4, 24.7)
CFU-GM 68.4 (14.0, 148.6) 0.0 (4.08) 21.0 ( 18.1, 78.6) 24.3 ( 37.5, 147.1)  7.3 ( 26.0, 16.1)
aCore covariates included mother’s age, parity, gestation duration, gender of baby (male or female), delivery time (night or day) and study site (ACBP or T-NEMC).
bUnadjusted
geometric means. The unit for the stem cell measurements was per 1000 MNC. Statistical significance of Po0.05 are given in bold.
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developmental time to undergo a normal course of differentiation,
or if such infants build up a stem cell reserve for growth
compensation during the postnatal period. In any case, our
J-shaped relation observed between birth weight and stem cell
measurements requires further confirmation as ethnicity-specific
results showed a linear relation in the considerably larger group of
Caucasian cord blood samples.
Finally, we examined cord blood plasma IGF-1 levels in relation
to stem cell levels and birth weight. Insulin-like growth factor-1
had a positive association with stem cell measurements in our
samples (Savarese et al, 2007) and was strongly associated with
birth weight (geometric means were 41.18, 57.86, 78.45 and
102.77ngml
 1, respectively, for the four categories of birth weight
in Table 2 and in the literature (Bennett et al, 1983; Fant et al, 1993;
Reece et al, 1994)). The growth hormone/IGF-1 axis has been
suggested to serve as a master developmental regulator, coordinat-
ing stem cells in multiple organs (Ginestier and Wicha, 2007).
When we controlled for cord plasma IGF-1 levels, the associations
were considerably weakened. This would be expected if IGF-1
regulates stem cell potential and this is, in turn, a determinant of
birth weight. To determine whether birth weight is an accurate
reflection of stem cell potential, the focus should be on the results
without adjusting for IGF-1.
We conclude that there is a J- or U-shaped positive association
between birth weight and stem cell measurements, linear among
term newborns with normal-to-high birth weight and stronger
with the more primitive stem cell sub-population. The nonlinear
relationship, however, suggests that birth weight is not an
unequivocal indicator of stem cell potential in the context of a
prenatal origin of cancer risk. Quantitation of stem cell pools
might prove to be a more accurate predictor of cancer risk than
birth weight per se, in accordance with the stem cell burden
hypothesis.
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